The SULF2 protein is expressed in pancreatic cancer cells; both SULF1 and its homolog SULF2 have been shown to deferentially splice to regulate pancreatic tumor progression and have been proposed as both biomarkers and treatment targets [30,31,32,33]. This evidence concerns the gene SULF2 and familial pancreatic carcinoma.